157 related articles for article (PubMed ID: 17900309)
21. Lycopene metabolite, apo-10'-lycopenoic acid, inhibits diethylnitrosamine-initiated, high fat diet-promoted hepatic inflammation and tumorigenesis in mice.
Ip BC; Hu KQ; Liu C; Smith DE; Obin MS; Ausman LM; Wang XD
Cancer Prev Res (Phila); 2013 Dec; 6(12):1304-16. PubMed ID: 24085778
[TBL] [Abstract][Full Text] [Related]
22. Inhibition by acetaminophen of neoplastic initiation elicited in rat liver by the DNA-reactive hepatocarcinogen N-acetyl-2-aminofluorene.
Williams GM; Iatropoulos MJ; Jeffrey AM; Duan JD; Perrone CE
Eur J Cancer Prev; 2007 Dec; 16(6):528-34. PubMed ID: 18090125
[TBL] [Abstract][Full Text] [Related]
23. Persistent chemopreventive effect of S-adenosyl-L-methionine on the development of liver putative preneoplastic lesions induced by thiobenzamide in diethylnitrosamine-initiated rats.
Simile MM; Saviozzi M; De Miglio MR; Muroni MR; Nufris A; Pascale RM; Malvaldi G; Feo F
Carcinogenesis; 1996 Jul; 17(7):1533-7. PubMed ID: 8706260
[TBL] [Abstract][Full Text] [Related]
24. Resveratrol-mediated chemoprevention of diethylnitrosamine-initiated hepatocarcinogenesis: inhibition of cell proliferation and induction of apoptosis.
Bishayee A; Dhir N
Chem Biol Interact; 2009 May; 179(2-3):131-44. PubMed ID: 19073162
[TBL] [Abstract][Full Text] [Related]
25. β-ionone inhibits nonalcoholic fatty liver disease and its association with hepatocarcinogenesis in male Wistar rats.
Miranda MLP; Furtado KS; de Oliveira Andrade F; Heidor R; da Cruz RS; Nogueira MS; de Castro IA; Purgatto E; Barbisan LF; Moreno FS
Chem Biol Interact; 2019 Aug; 308():377-384. PubMed ID: 31150631
[TBL] [Abstract][Full Text] [Related]
26. High-dose treatment with lanreotide of patients with advanced neuroendocrine gastrointestinal tumors: clinical and biological effects.
Eriksson B; Renstrup J; Imam H; Oberg K
Ann Oncol; 1997 Oct; 8(10):1041-4. PubMed ID: 9402179
[TBL] [Abstract][Full Text] [Related]
27. No evidence for an inhibitory effect of beta-carotene or of canthaxanthin on the initiation of liver preneoplastic foci by diethylnitrosamine in the rat.
Astorg P; Gradelet S; Bergès R; Suschetet M
Nutr Cancer; 1996; 25(1):27-34. PubMed ID: 8837859
[TBL] [Abstract][Full Text] [Related]
28. Different inhibitory effects in the early and late phase of treatment with KAT-681, a liver-selective thyromimetic, on rat hepatocarcinogenesis induced by 2-acetylaminofluorene and partial hepatectomy after diethylnitrosamine initiation.
Hayashi M; Tamura T; Kuroda J; Ohnota H; Shibata N; Akahane M; Kashida Y; Mitsumori K
Toxicol Sci; 2005 Mar; 84(1):22-8. PubMed ID: 15564315
[TBL] [Abstract][Full Text] [Related]
29. Possible involvement of oxidative stress in fenofibrate-induced hepatocarcinogenesis in rats.
Nishimura J; Dewa Y; Okamura T; Muguruma M; Jin M; Saegusa Y; Umemura T; Mitsumori K
Arch Toxicol; 2008 Sep; 82(9):641-54. PubMed ID: 18253720
[TBL] [Abstract][Full Text] [Related]
30. Involvement of NF-κB/PI3K/AKT signaling pathway in the protective effect of prunetin against a diethylnitrosamine induced hepatocellular carcinogenesis in rats.
Li G; Qi L; Chen H; Tian G
J Biochem Mol Toxicol; 2022 May; 36(5):e23016. PubMed ID: 35239232
[TBL] [Abstract][Full Text] [Related]
31. Involvement of multiple cell cycle aberrations in early preneoplastic liver cell lesions by tumor promotion with thioacetamide in a two-stage rat hepatocarcinogenesis model.
Kimura M; Fujii Y; Yamamoto R; Yafune A; Hayashi SM; Suzuki K; Shibutani M
Exp Toxicol Pathol; 2013 Nov; 65(7-8):979-88. PubMed ID: 23474136
[TBL] [Abstract][Full Text] [Related]
32. Lanreotide treatment of metastatic hepatocellular carcinoma resulting in partial regression and more than 3 years of progression-free survival.
Borbath I; Lhommel R; Guiot Y; Coche E; Sempoux C
Acta Gastroenterol Belg; 2012 Jun; 75(2):270-3. PubMed ID: 22870795
[TBL] [Abstract][Full Text] [Related]
33. Cyclin dependent kinase inhibitor p27(kip1) expression and subcellular localization in relation to cell proliferation in hepatocellualr carcinoma.
Shehata MA; Nosseir HR; Nagy HM; Farouk G
Egypt J Immunol; 2006; 13(1):115-30. PubMed ID: 17974156
[TBL] [Abstract][Full Text] [Related]
34. Protective effects of Celastrol on diethylnitrosamine-induced hepatocellular carcinoma in rats and its mechanisms.
Chang W; He W; Li PP; Song SS; Yuan PF; Lu JT; Wei W
Eur J Pharmacol; 2016 Aug; 784():173-80. PubMed ID: 27181068
[TBL] [Abstract][Full Text] [Related]
35. β-ionone modulates the expression of miRNAs and genes involved in the metastatic phenotype of microdissected persistent preneoplastic lesions in rats submitted to hepatocarcinogenesis.
Furtado KS; de Oliveira Andrade F; Campos A; Rosim MP; Vargas-Mendez E; Henriques A; De Conti A; Scolastici C; Barbisan LF; Carvalho RF; Moreno FS
Mol Carcinog; 2017 Jan; 56(1):184-196. PubMed ID: 27061051
[TBL] [Abstract][Full Text] [Related]
36. Therapeutic 188Re-lanreotide: determination of radiopharmacokinetic parameters in rats.
Molina-Trinidad EM; de Murphy CA; Jung-Cook H; Stack EM; Pedraza-Lopez M; Morales-Marquez JL; Serrano GV
J Pharm Pharmacol; 2010 Apr; 62(4):456-61. PubMed ID: 20604834
[TBL] [Abstract][Full Text] [Related]
37. Potential chemoprevention of diethylnitrosamine-induced hepatocarcinogenesis in rats: myrrh (Commiphora molmol) vs. turmeric (Curcuma longa).
El-Shahat M; El-Abd S; Alkafafy M; El-Khatib G
Acta Histochem; 2012 Sep; 114(5):421-8. PubMed ID: 21871653
[TBL] [Abstract][Full Text] [Related]
38. Gefitinib, an EGFR inhibitor, prevents hepatocellular carcinoma development in the rat liver with cirrhosis.
Schiffer E; Housset C; Cacheux W; Wendum D; Desbois-Mouthon C; Rey C; Clergue F; Poupon R; Barbu V; Rosmorduc O
Hepatology; 2005 Feb; 41(2):307-14. PubMed ID: 15660382
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of the development of rat liver preneoplastic lesions by verapamil and dexverapamil.
Ghia M; Mereto E; Cavanna M; Brambilla G
Anticancer Res; 1996; 16(4A):1739-41. PubMed ID: 8712693
[TBL] [Abstract][Full Text] [Related]
40. Anti-cancer effects of Ajwa dates (Phoenix dactylifera L.) in diethylnitrosamine induced hepatocellular carcinoma in Wistar rats.
Khan F; Khan TJ; Kalamegam G; Pushparaj PN; Chaudhary A; Abuzenadah A; Kumosani T; Barbour E; Al-Qahtani M
BMC Complement Altern Med; 2017 Aug; 17(1):418. PubMed ID: 28830415
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
